Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 409

1.

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.

Abs R, Bengtsson BA, Hernberg-Stâhl E, Monson JP, Tauber JP, Wilton P, Wüster C.

Clin Endocrinol (Oxf). 1999 Jun;50(6):703-13.

PMID:
10468941
[PubMed - indexed for MEDLINE]
2.

Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.

Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stâhl E, Thorén M, Westberg B, Wilton P, Wüster C.

Clin Endocrinol (Oxf). 2000 Sep;53(3):281-9.

PMID:
10971444
[PubMed - indexed for MEDLINE]
3.

Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.

Feldt-Rasmussen U, Wilton P, Jonsson P; KIMS Study Group; KIMS International Board.

Growth Horm IGF Res. 2004 Jun;14 Suppl A:S51-8.

PMID:
15135778
[PubMed - indexed for MEDLINE]
4.

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.

Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P; KIMS Study Group.

Growth Horm IGF Res. 2005 Oct;15(5):349-59.

PMID:
16168692
[PubMed - indexed for MEDLINE]
5.

Long-term experience with GH replacement therapy: efficacy and safety.

Monson JP.

Eur J Endocrinol. 2003 Apr;148 Suppl 2:S9-14. Review.

PMID:
12670295
[PubMed - indexed for MEDLINE]
Free Article
6.

Influences on quality of life in GH deficient adults and their effect on response to treatment.

Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM.

Clin Endocrinol (Oxf). 1999 Nov;51(5):565-73.

PMID:
10594517
[PubMed - indexed for MEDLINE]
7.

Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.

Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, Wüster C; KIMS International Study Board of KIMS Study Group.

Eur J Endocrinol. 2002 Jan;146(1):67-74.

PMID:
11751070
[PubMed - indexed for MEDLINE]
Free Article
8.

A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.

Davies JS, Obuobie K, Smith J, Rees DA, Furlong A, Davies N, Evans LM, Scanlon MF.

Clin Endocrinol (Oxf). 2000 Mar;52(3):295-303.

PMID:
10718827
[PubMed - indexed for MEDLINE]
9.

Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania.

Moock J, Albrecht C, Friedrich N, Völzke H, Nauck M, Koltowska-Haggström M, Kohlmann T, Wallaschofski H.

Eur J Endocrinol. 2009 Jan;160(1):17-24. doi: 10.1530/EJE-08-0738. Epub 2008 Oct 30.

PMID:
18974232
[PubMed - indexed for MEDLINE]
Free Article
10.

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.

Kendall-Taylor P, Jönsson PJ, Abs R, Erfurth EM, Koltowska-Häggström M, Price DA, Verhelst J.

Eur J Endocrinol. 2005 Apr;152(4):557-67.

PMID:
15817911
[PubMed - indexed for MEDLINE]
Free Article
11.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001. Epub 2008 Feb 20.

PMID:
18282776
[PubMed - indexed for MEDLINE]
12.

The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.

Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2001 Apr;54(4):525-32.

PMID:
11318789
[PubMed - indexed for MEDLINE]
13.

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Góth MI, Wilton P, Koltowska-Häggström M.

Eur J Endocrinol. 2006 Jul;155(1):79-90.

PMID:
16793953
[PubMed - indexed for MEDLINE]
Free Article
14.

Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.

Kreitschmann-Andermahr I, Poll EM, Reineke A, Gilsbach JM, Brabant G, Buchfelder M, Fassbender W, Faust M, Kann PH, Wallaschofski H.

Growth Horm IGF Res. 2008 Dec;18(6):472-8. doi: 10.1016/j.ghir.2008.08.007. Epub 2008 Oct 1.

PMID:
18829359
[PubMed - indexed for MEDLINE]
15.

The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.

Spielhagen C, Schwahn C, Möller K, Friedrich N, Kohlmann T, Moock J, Kołtowska-Häggström M, Nauck M, Buchfelder M, Wallaschofski H.

Growth Horm IGF Res. 2011 Feb;21(1):1-10. doi: 10.1016/j.ghir.2010.10.005. Epub 2010 Nov 19.

PMID:
21093334
[PubMed - indexed for MEDLINE]
16.

Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.

Schneider HJ, Oertel H, Murck H, Pollmächer T, Stalla GK, Steiger A.

Psychoneuroendocrinology. 2005 Jan;30(1):29-37.

PMID:
15358440
[PubMed - indexed for MEDLINE]
17.

Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.

Kelestimur F, Jonsson P, Molvalilar S, Gomez JM, Auernhammer CJ, Colak R, Koltowska-Häggström M, Goth MI.

Eur J Endocrinol. 2005 Apr;152(4):581-7.

PMID:
15817914
[PubMed - indexed for MEDLINE]
Free Article
18.

Cardiovascular risk factors in hypopituitary GH-deficient adults.

Verhelst J, Abs R.

Eur J Endocrinol. 2009 Nov;161 Suppl 1:S41-9. doi: 10.1530/EJE-09-0291. Epub 2009 Aug 14. Review.

PMID:
19684057
[PubMed - indexed for MEDLINE]
Free Article
19.

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

Svensson J, Mattsson A, Rosén T, Wirén L, Johannsson G, Bengtsson BA, Koltowska Häggström M; Swedish KIMS National Board.

Growth Horm IGF Res. 2004 Jun;14(3):207-15.

PMID:
15125882
[PubMed - indexed for MEDLINE]
20.

Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.

Malik IA, Foy P, Wallymahmed M, Wilding JP, MacFarlane IA.

Clin Endocrinol (Oxf). 2003 Jul;59(1):75-81.

PMID:
12807507
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk